Reads a new business model for organizational-rejection triggers — margin conflict, sales-process conflict, cannibalization fear — inside the client's own organization, and designs a protected sandbox so internal 'antibodies' don't kill the experiment before it's tested.
Scanned 9/6/2026
Install to Claude Code
npx -y skills add Pilot2Service/AI-Business-Designer --skill bmc-antibody-and-sandbox-design --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Bmc Antibody And Sandbox Design?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/pilot2service-bmc-antibody-and-sandbox-design)More formats (shields.io, HTML) on the badges page.
---
name: bmc-antibody-and-sandbox-design
description: "Reads a new business model for organizational-rejection triggers — margin conflict, sales-process conflict, cannibalization fear — inside the client's own organization, and designs a protected sandbox so internal 'antibodies' don't kill the experiment before it's tested."
---
# BMC Antibody and Sandbox Design
## Purpose
Every other skill in this pack judges whether a business model is
GOOD. This skill judges something different: whether the client's OWN
organization will let it survive long enough to find out. A new model
often threatens existing incentives, processes, or identities inside the
company that's trying to build it — the biological metaphor
practitioners use is "corporate antibodies": the organization reacts to
something unfamiliar the way a body reacts to a mismatched transplant,
attacking it regardless of its merit. Use this once a candidate model
exists (after `bmc-innovation-pattern-matching` or
`bmc-canvas-clarity-and-iteration`) and before it's handed to the parts
of the organization that didn't design it.
## Anchored in research
The "corporate antibodies" concept is independently documented under
this exact name across multiple sources: Harvard Business Review, ["Get
the Corporate Antibodies on Your
Side"](https://hbr.org/2012/05/get-the-corporate-antibodies-o) (2012);
and a substantial, independently-arrived-at body of corporate-innovation
writing using the same biological metaphor (Forbes, Wellspring, Idea to
Value, CIO.com). The taxonomy of antibody types in Step 2 below is this
pack's own synthesis of the recurring patterns across that literature,
not a direct reproduction of any single source's list — treat it as a
working checklist, not a citation.
## Method
1. **Compare the new model against the existing one, block by block,
looking for conflict — not fit.** For each canvas block, ask: does
this new model ask anyone in the existing organization to act against
their own current incentives, metrics, or identity? The four most
common conflict points:
- **Margin conflict** — the new model has structurally lower margins
than the core business, so anyone measured on blended margin has a
reason to starve it of resources or deprioritize it.
- **Sales-process conflict** — the new model requires a different
sales motion (self-serve vs. enterprise, subscription vs.
one-time), and the existing sales team is compensated on the old
motion — they will not sell what doesn't pay their commission
structure, regardless of stated company priority.
- **Cannibalization fear** — the new model could shrink revenue from
an existing, currently-successful line, and whoever owns that line's
numbers has a direct reason to slow-walk or undermine it.
- **Identity/brand conflict** — the new model doesn't match "who we
are" in the organization's own self-story (a premium brand entering
a low-cost segment, a B2B company going direct-to-consumer) — this
resistance is often the least visible because it's expressed as
"that's not really us" rather than a stated business objection.
2. **Read for early antibody activity, not just structural risk.**
Signals that antibodies are already active, before the model has even
launched: sudden compliance or process objections that were never
raised for similar past initiatives; a "yes, but" response from every
functional lead consulted; resourcing requests that get acknowledged
verbally and then quietly deprioritized; the project being reframed
internally as a "pilot" or "experiment" by people who weren't asked
whether it should be one.
3. **Design the sandbox — don't just document the risk.** Once conflict
points are named, choose protective structures matched to the
specific conflict:
- **Margin conflict** → a separate cost center or P&L line, so the
new model isn't blended into a metric that makes it look like a
failure by the old business's standard.
- **Sales-process conflict** → a dedicated sales channel or team not
carrying the old quota/commission structure — not the existing
sales team "also" selling it on the side.
- **Cannibalization fear** → an explicit executive mandate that
cannibalization of the old line, if it happens, is an accepted and
expected outcome, stated before launch, not litigated after the
first quarter it happens.
- **Identity conflict** → a distinct name, brand, or team identity
for the new initiative, so it isn't forced to inherit expectations
("but that's not how we do things") that only apply to the core
business.
- **General, any conflict type** → a named, senior executive sponsor
whose own performance isn't measured by the core business's
existing metrics, and a time-boxed exemption from the standard
approval/procurement/compliance gates that assume core-business
norms.
4. **Set an explicit integration trigger.** A sandbox that never ends is
its own failure mode — decide in advance what evidence (revenue
threshold, validated demand, operational maturity) triggers folding
the initiative back into normal organizational structure, and who
makes that call.
5. **Name the antibody risk out loud to the sponsor, not just internally
to the design team.** The point of this skill isn't to quietly work
around resistance — it's to make the risk visible enough that the
people with authority to build a sandbox actually do, before the
antibodies get there first.
## What this skill does NOT do
- Doesn't guarantee the sandbox will hold — organizational politics can
overrule any structural protection; this skill reduces predictable
risk, it doesn't eliminate it.
- Doesn't replace `bmc-canvas-diagnostic-reading` or
`bmc-innovation-pattern-matching` for judging whether the model itself
is sound — a model can be well-designed and still get killed by
antibodies, or poorly designed and survive because the sandbox is
strong; this skill only addresses the second axis.
- Doesn't apply meaningfully to a solo founder building something new
with no existing organization to conflict with — this is specifically
for a new model being introduced INTO an existing company (including
a growth-stage client adding a new line, not just large enterprises).
## Refinement notes
- Which of the four conflict types have you actually seen kill an
otherwise good model in your own client work — and which sandbox
structure actually held?
- What's the earliest antibody signal you personally watch for, before
it's obvious?
- Have you ever seen a sandbox stay open too long and become its own
problem? What triggered closing it?
## Continue from here
- Use after: `bmc-innovation-pattern-matching/SKILL.md` or
`bmc-canvas-clarity-and-iteration/SKILL.md` — once a candidate model
exists.
- Use before: handing the model to functions outside the design team
(sales, finance, operations) for execution.
- This pack's shared guardrails: `../../CLAUDE.md`
## References
- `../../references/bmc-source-material-notes.md` — source material background
- `../../references/bmc-resilience-heuristics-research.md` — selection and grounding notes for this skill and its siblings
- `../../CLAUDE.md` — this pack's shared guardrails
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!